Related Experiment Video
Updated: Dec 26, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic
Takaaki Toyama1,2, Takehiko Mori1,3, Jun Kato1
1Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Abstract:
Nontuberculous mycobacteria are ubiquitous in water and soil, and the subset of rapidly growing mycobacteria species can cause severe infections in immunocompromised patients. Solid organ or hematopoietic stem cell transplantation (HSCT) recipients are known to be susceptible to infection by nontuberculous mycobacteria. The nontuberculous mycobacteria species Mycobacterium massiliense (M massiliense) has been classified as a rapidly growing mycobacteria and recognized as a pathogen causing lung and soft tissue infections in humans. However, there have been only a few reported cases of M massiliense infection after solid organ transplantation and HSCT. We herein report another case of M massiliense infection after allogeneic HSCT, which manifested as soft tissue infection, lung infection, and bacteremia.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

